Reperfusion with the intravenous tissue plasminogen activator (recombinant tissue-type plasminogen activator (rt-PA)) and endovascular therapy (EVT) improve outcomes in acute ischemic stroke (AIS) patients [1]. This evidence concerns the gene PLAT and androgen insensitivity syndrome.